Arizona State Retirement System Has $1.24 Million Stake in Hims & Hers Health, Inc. (NYSE:HIMS)

Arizona State Retirement System raised its position in Hims & Hers Health, Inc. (NYSE:HIMS) by 23.4% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 51,327 shares of the company’s stock after purchasing an additional 9,723 shares during the period. Arizona State Retirement System’s holdings in Hims & Hers Health were worth $1,241,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently modified their holdings of HIMS. Crewe Advisors LLC acquired a new position in shares of Hims & Hers Health in the 4th quarter worth approximately $28,000. Raleigh Capital Management Inc. increased its stake in shares of Hims & Hers Health by 1,100.0% in the 4th quarter. Raleigh Capital Management Inc. now owns 1,200 shares of the company’s stock valued at $29,000 after acquiring an additional 1,100 shares in the last quarter. Smartleaf Asset Management LLC increased its stake in shares of Hims & Hers Health by 4,415.6% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the company’s stock valued at $36,000 after acquiring an additional 1,413 shares in the last quarter. US Bancorp DE increased its stake in shares of Hims & Hers Health by 346.7% in the 4th quarter. US Bancorp DE now owns 1,943 shares of the company’s stock valued at $47,000 after acquiring an additional 1,508 shares in the last quarter. Finally, Venturi Wealth Management LLC bought a new stake in shares of Hims & Hers Health in the 4th quarter valued at $48,000. Institutional investors and hedge funds own 63.52% of the company’s stock.

Hims & Hers Health Price Performance

HIMS opened at $34.00 on Thursday. The company has a market capitalization of $7.55 billion, a price-to-earnings ratio of 77.27 and a beta of 1.37. The firm’s fifty day moving average price is $38.23 and its two-hundred day moving average price is $27.90. Hims & Hers Health, Inc. has a 1 year low of $11.20 and a 1 year high of $72.98.

Hims & Hers Health (NYSE:HIMS) last posted its quarterly earnings data on Monday, February 24th. The company reported $0.11 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.09 by $0.02. The firm had revenue of $481.14 million for the quarter, compared to the consensus estimate of $494.56 million. Hims & Hers Health had a net margin of 8.19% and a return on equity of 10.97%. As a group, equities analysts anticipate that Hims & Hers Health, Inc. will post 0.29 EPS for the current year.

Analyst Ratings Changes

Several research firms have recently weighed in on HIMS. Citigroup reiterated a “sell” rating and issued a $27.00 price objective on shares of Hims & Hers Health in a research note on Thursday, March 6th. Truist Financial lifted their price objective on shares of Hims & Hers Health from $24.00 to $39.00 and gave the company a “hold” rating in a research note on Wednesday, February 26th. Morgan Stanley lowered shares of Hims & Hers Health from an “overweight” rating to an “equal weight” rating and lifted their price objective for the company from $42.00 to $60.00 in a research note on Tuesday, February 18th. BTIG Research began coverage on shares of Hims & Hers Health in a research note on Tuesday, January 7th. They issued a “buy” rating and a $35.00 price objective for the company. Finally, TD Cowen reiterated a “buy” rating and issued a $28.00 price objective on shares of Hims & Hers Health in a research note on Wednesday, November 20th. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat.com, Hims & Hers Health currently has an average rating of “Hold” and a consensus target price of $37.23.

Insiders Place Their Bets

In related news, CEO Andrew Dudum sold 128,127 shares of the business’s stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $58.27, for a total value of $7,465,960.29. Following the transaction, the chief executive officer now directly owns 97,687 shares of the company’s stock, valued at approximately $5,692,221.49. The trade was a 56.74 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Michael Chi sold 7,500 shares of the business’s stock in a transaction dated Thursday, December 19th. The stock was sold at an average price of $26.00, for a total transaction of $195,000.00. Following the completion of the transaction, the insider now directly owns 193,601 shares in the company, valued at $5,033,626. This trade represents a 3.73 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 969,191 shares of company stock valued at $34,005,375 in the last three months. 17.71% of the stock is currently owned by insiders.

About Hims & Hers Health

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.